Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADMP
FechaHoraFuenteTítuloSímboloCompañía
11/05/202019:35GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on SYMJEPI Products and Announces Distribution and Commercialization Agreement for SYM...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
29/04/202015:59Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/04/202005:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
23/04/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Publication Demonstrating PET Scan Results of Higher Dose Naloxone in MonkeysNASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/04/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Production of Additional Drugs by its US Compounding Subsidiary to Aid in the COVID-19 Pande...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
17/04/202015:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/04/202015:05GlobeNewswire Inc.Adamis Pharmaceuticals Announces Receipt of Loan Proceeds Under Paycheck Protection ProgramNASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/04/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Production of Products by its Subsidiary US Compounding to Aid in the COVID-19 PandemicNASDAQ:ADMPAdamis Pharmaceuticals Corporation
30/03/202015:40GlobeNewswire Inc.Adamis Pharmaceuticals Announces 2019 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/03/202017:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/03/202016:17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/03/202015:46Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
28/02/202008:34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/02/202015:54Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/02/202008:15GlobeNewswire Inc.Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/02/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update Regarding ZIMHINASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/02/202016:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/02/202009:15Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/12/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides an Update on ZIMHINASDAQ:ADMPAdamis Pharmaceuticals Corporation
25/11/201907:00GlobeNewswire Inc.Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHINASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/11/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Publication of Comparative Pharmacokinetics of Community Use Naloxone FormulationsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/11/201915:28GlobeNewswire Inc.Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/11/201915:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/11/201915:05GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Third Quarter 2019 Earnings Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
04/11/201919:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Regulatory Update for Its Higher Dose Naloxone Pre-Filled SyringeNASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/10/201917:59Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
08/10/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Presentation of ZIMHI data at IHV Scientific MeetingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/10/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Commercial Partnership with Emerge Health for SYMJEPI® in Australia and New ZealandNASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/09/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Presentation Pertaining to Its High Dose Naloxone Product Candidate at IHV Scientific Meetin...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
03/09/201908:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update for Naloxone Product CandidateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP